Navigation Links
The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement
Date:7/22/2014

Piscataway, NJ (PR Web) July 21, 2014 (PRWEB) July 23, 2014

The New Jersey Center for Biomaterials, at Rutgers University.

The goal of the Symposium is to exchange information and ideas across the full spectrum of scientists working in the biomaterials field, by focusing on selected research and development topics that represent the most promising directions for ultimate medical application. Activities have been programmed to:

  •     Provide faculty and government scientists with opportunities for high-level scientific interactions with leading investigators in similar and complementary disciplines; and with commercially oriented biomaterials users
  •     Provide students and postdoctoral associates with opportunities both to learn about the most advanced biomaterials-related research, and to present their own research in a professional forum; and to interact with industrial scientists in furtherance of exploring future career options
  •     Provide industrial scientists with access to leading-edge academic biomaterials researchers, and the opportunity to contribute to defining university-based research directions
  •     Provide clinicians with current information on biomaterials research and product development, and the opportunity to shape R&D programs through clinical input

Registration for the 12th NJ Symposium on Biomaterials Science is available at http://www.njbiomaterials.org/biomaterials-symposia.htm

The New Jersey Center for Biomaterials (NJCBM) was founded in 1997. Based at Rutgers, the State University of New Jersey, the center spans academia, industry and government. Staffed by biomaterial scientists, the Center works to improve health care and quality of life by developing advanced biomedical products for tissue repair and replacement as well as the delivery of pharmaceutical agents. The Center’s technologies have been translated into clinical and pre-clinical products including surgical meshes, cardiovascular stents, bone regeneration scaffolds, and ocular drug delivery systems.

The Society For Biomaterials is a multidisciplinary society of academic, healthcare, governmental and business professionals in the US, dedicated to promoting advances in all aspects of biomaterial science, education and professional standards.

Media Contact:

Louli Kourkounakis
(732) 445 0488 ext. 40001
symposium(at)dls(dot)rutgers(dot)edu

Read the full story at http://www.prweb.com/releases/2014/07/prweb12033279.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
2. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
3. Agendia to Present Five Abstracts at 2011 San Antonio Breast Cancer Symposium
4. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
5. Genomic Health Presents Results From First Clinical Decision Making Study of Oncotype DX® Colon Cancer at the 2012 Gastrointestinal Cancers Symposium
6. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
7. Amarantus BioSciences Featured in BioWorld Today, Brewer Sports Symposium and Opportunist Magazine
8. Tanke BioSciences To Host Leading Symposium On Food Safety, June 24-25
9. Access Pharmaceuticals to Report New MuGard Clinical Trial Data This Week at the MASCC/ISOO Symposium in New York City
10. Van Andel Institute Research Symposium Showcases Latest Developments In Parkinsons Research
11. Genomic Health Announces Presentation of Six Studies at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... commercializing products to treat rare diseases where there is ... be hosting an Investor Webcast Event Friday, December 16, ... innate defense regulators (IDRs) as a new drug class, ... the recently announced and published Phase 2 clinical data ...
(Date:12/8/2016)... Dec. 8, 2016 Savannah River Remediation ... and selected NewTechBio,s NT-MAX Lake & Pond ... beneficial bacteria, in conjunction with Hexa Armor/ Rhombo ... with National Pollutant Discharge Elimination System requirements. ... a steady history of elevated pH levels, above ...
(Date:12/8/2016)... to fuel Philadelphia,s innovative digital ... Southeastern Pennsylvania (" Ben Franklin "); Independence ... Cross; and Safeguard Scientifics ("Safeguard") (NYSE: SFE ... funding initiative over a four year period to grow ... burgeoning economic vitality in digital health, Ben Franklin ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. ... and expansion clinical trial for its lead drug candidate, AC0010, at the World ... trial was to determine the safety, antitumor activity, and recommended phase II dosage ...
Breaking Biology Technology:
(Date:12/7/2016)... --  Veridium , a leader in biometrics-based authentication ... James Stickland . Stickland, a seasoned financial ... served in senior executive roles for HSBC, JPMorgan ... a pipeline of venture capital and accelerating innovation ... as managing director of U.K.-based fintech firm Red ...
(Date:12/2/2016)... 1, 2016 The report "Biometric ... Future Technology (Iris Recognition System), Vehicle Type (Passenger ... Forecast to 2021", published by MarketsandMarkets, the market ... 2016, and is projected to grow to USD ... 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/29/2016)... , Nov. 29, 2016   Neurotechnology ... and object recognition technologies, today released FingerCell ... fingerprint recognition solutions that run on low-power, ... template using less than 128KB of memory, ... devices that have limited on-board resources, such ...
Breaking Biology News(10 mins):